K060417

Substantially Equivalent

MODIFICATION TO QUANTIMETRIX URINE DRUGS OF ABUSE CONTROL

Applicant
Quantimetrix Corp.
Product code
DIF
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Redondo Beach, CA, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.